Amarin to Report Fourth Quarter and Year-End 2012 Results and Host Conference Call on February 28, 2013

Amarin to Report Fourth Quarter and Year-End 2012 Results and Host Conference
Call on February 28, 2013

BEDMINSTER, N.J., and DUBLIN, Ireland, Feb. 22, 2013 (GLOBE NEWSWIRE) --
Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on
the commercialization and development of therapeutics to improve
cardiovascular health, today announced that it will host a conference call
with members of Amarin senior management to discuss the company's fourth
quarter and year-end 2012 financial results and 2013 business initiatives on
Thursday, Feb. 28, 2013, at 4:30 p.m. EST. The conference call will follow the
anticipated release of the company's fourth quarter and year-end 2012
financial results earlier that day.

To participate in the call, please dial 877-407-8033 within the United States
or 201-689-8033 from outside the United States. A replay of the call will be
made available for a period of two weeks following the conference call. To
hear a replay of the call dial 877-660-6853 (inside the United States) or
201-612-7415 (outside the United States). A replay of the call will also be
available through the company's website shortly after the call. For both
dial-in numbers please use conference ID 408629. The conference call can also
be heard live via the investor relations section of the company's website at
www.amarincorp.com.

About Amarin

Amarin Corporation plc is a biopharmaceutical company focused on the
commercialization and development of therapeutics to improve cardiovascular
health. Amarin's product development program leverages its extensive
experience in lipid science and the potential therapeutic benefits of
polyunsaturated fatty acids. Vascepa^® (icosapent ethyl), Amarin's first FDA
approved product, is a patented, ultra pure omega-3 fatty acid product
comprising not less than 96% EPA and is available by prescription. For more
information about Vascepa visit www.vascepa.com. For more information about
Amarin visit www.amarincorp.com.

The Amarin Corporation plc logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=13817

CONTACT: Amarin contact information:
         Stephen Schultz or Joseph Bruno
         Investor Relations and Corporate Communications
         Amarin Corporation
         In U.S.: +1 (908) 719-1315
         investor.relations@amarincorp.com

company logo